Skip to main content

Table 5 Scoring model for the prediction of non-AIDS-defining cancers (NADCs) in HIV-infected patients (N = 1001)

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Score

No. of NADCs/ Non-NADCs

Cumulative incidence rate of NADCs at 5 years (95% CI)

Cumulative incidence rate of NADCs at 10 years (95% CI)

Hazard ratio (95% CI)

0

2/ 222

0.9 (0.2–3.7)

0.9 (0.2–3.7)

1 (reference)

1

1/ 91

0

1.4 (0.2–9.7)

0.9 (0.08–10.2)

2

6/ 273

0.4 (0.1–2.8)

1.4 (0.4–4.4)

2.5 (0.5–12.3)

3

8/ 174

2.9 (1.2–6.9)

2.9 (1.2–6.9)

5.1 (1.1–23.9)

4

11/ 101

5.8 (2.7–12.5)

10.7 (5.5–20.4)

12.6 (2.8–56.7)

≥5

33/ 79

20.2 (13.5–29.7)

41.3 (29.7–55.3)

53.2 (12.7–222.5)

Total

61/ 940

  

P for trend < 0.001

  1. C-statistics: 0.8 (95%CI, 0.8–0.9, P < 0.001)
  2. Note. Based on the final model’s regression coefficients (Table 4), 1 point each was assigned to blood transmission, and HBV, 2 points each were assigned to age 40–49, smoker, and IDU, 3 points was assigned to age 50–59, age 60–69, and 4 points was assigned to age ≥ 70. Abbreviations: CI confidence interval, HBV hepatitis B virus, IDU injection drug use, NADCs non-AIDS-defining cancers